You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Two weeks of rifaximin relieves global symptoms and bloating in people with IBS without constipation

https://doi.org/10.1136/ebm1404

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests BS has received grants from Takeda, Prometheus, Movetis. Advisor for Salix, Prometheus, Ironwood, Movetis, AstraZeneca.